These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31533602)

  • 1. 2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase Inhibitors.
    Al-Attraqchi OHA; Venugopala KN
    Curr Comput Aided Drug Des; 2020; 16(6):682-697. PubMed ID: 31533602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile.
    Kumar V; Gupta MK; Singh G; Prabhakar YS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):515-22. PubMed ID: 22304474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation.
    Zhou Q; Cai J; Qin F; Liu J; Li C; Xiong W; Wang Y; Xu C; Wu H
    Bioorg Med Chem; 2024 Jan; 97():117542. PubMed ID: 38104495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship.
    Buchholz M; Heiser U; Schilling S; Niestroj AJ; Zunkel K; Demuth HU
    J Med Chem; 2006 Jan; 49(2):664-77. PubMed ID: 16420052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
    Sharma MC
    Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
    Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
    Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening.
    Szaszkó M; Hajdú I; Flachner B; Dobi K; Magyar C; Simon I; Lőrincz Z; Kapui Z; Pázmány T; Cseh S; Dormán G
    Mol Divers; 2017 Feb; 21(1):175-186. PubMed ID: 28070724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationships of imidazole-containing farnesyltransferase inhibitors using different chemometric methods.
    Shayanfar A; Ghasemi S; Soltani S; Asadpour-Zeynali K; Doerksen RJ; Jouyban A
    Med Chem; 2013 May; 9(3):434-48. PubMed ID: 22920090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors.
    Xu C; Wang YN; Wu H
    J Med Chem; 2021 May; 64(10):6549-6565. PubMed ID: 34000808
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kumar A; Bagri K; Nimbhal M; Kumar P
    J Biomol Struct Dyn; 2021 Nov; 39(18):7181-7193. PubMed ID: 32795153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
    Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
    Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.
    Xu C; Zou H; Yu X; Xie Y; Cai J; Shang Q; Ouyang N; Wang Y; Xu P; He Z; Wu H
    ChemistryOpen; 2021 Sep; 10(9):877-881. PubMed ID: 33377311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of flavonoids on human glutaminyl cyclase.
    Li M; Dong Y; Yu X; Zou Y; Zheng Y; Bu X; Quan J; He Z; Wu H
    Bioorg Med Chem; 2016 May; 24(10):2280-6. PubMed ID: 27061673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators.
    Schilling S; Niestroj AJ; Rahfeld JU; Hoffmann T; Wermann M; Zunkel K; Wasternack C; Demuth HU
    J Biol Chem; 2003 Dec; 278(50):49773-9. PubMed ID: 14522962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease.
    Li M; Dong Y; Yu X; Li Y; Zou Y; Zheng Y; He Z; Liu Z; Quan J; Bu X; Wu H
    J Med Chem; 2017 Aug; 60(15):6664-6677. PubMed ID: 28700245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.